Cittadine Andrew
- SEC CIK
- 0001863624
No open-market purchases or sales filed in the past year.
Current role at each company
- MNPR Monopar TherapeuticsChief Operating Officeras of Jul 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cittadine Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 (view filing) | Jun 18-20 | 3 days | Cittadine AndrewChief Operating Officer | PPurchase | +32.5K | $0.7843 | +$25.5K | +21.2%186.1K after | 2 lots |
| Jun 17, 2024 (view filing) | Jun 13-17 | 4 days | Cittadine AndrewChief Operating Officer | PPurchase | +36.0K | $0.9133 | +$32.9K | +30.6%153.6K after | 3 lots |
| Jun 5, 2024 (view filing) | Jun 3-4 | 2 days | Cittadine AndrewChief Operating Officer | PPurchase | +24.0K | $0.77 | +$18.5K | +25.6%117.6K after | 2 lots |
| May 31, 2024 (view filing) | May 29-31 | 2 days | Cittadine AndrewChief Operating Officer | PPurchase | +36.0K | $0.64 | +$23.0K | +62.5%93.6K after | 3 lots |
| Nov 16, 2022 (view filing) | Nov 14-15 | 2 days | Cittadine AndrewChief Operating Officer | PPurchase | +16.1K | $3.09 | +$49.7K | +196.1%24.2K after | 2 lots |